CRV’s George Zachary shares lessons from passing on Google, investing in health-tech after a cancer scare, and views on CRISPR and coronavirus risks.
CRV’s George Zachary shares lessons from passing on Google, investing in health-tech after a cancer scare, and views on CRISPR and coronavirus risks.
George Zachary
Join our newsletter to have all of this content + Exclusive Newsletter Bonus Content delivered to your inbox every week